Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis

por Szymańska, B., Matuszewski, M., Dembowski, J., Zdrojowy, R., Długosz, A.
Publicado 2018

Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer

por Matuszewski, M., Szymańska, B., Długosz, A., Małkiewicz, B., Dembowski, J., Piwowar, A.
Publicado 2018

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia

por Kern, D, Regl, G, Hofbauer, S W, Altenhofer, P, Achatz, G, Dlugosz, A, Schnidar, H, Greil, R, Hartmann, T N, Aberger, F
Publicado 2015